专题 · 美国
内部人成绩单
每位内部人的买入在此后 60 个交易日相对基准的结果。仅列出至少有 5 笔已到期买入的内部人。
有 5 笔及以上已到期买入的 314 名内部人中，120 名跑赢基准的次数过半（38.2%）。记录这么短，仅凭运气就会产生榜单的两端。
跑赢基准比例最高
| 内部人 | 最近买入的公司 | 已到期买入 | 跑赢基准 | 相对基准中位数 | 最差 |
|---|---|---|---|---|---|
| Casdin Capital, LLC | GeneDx Holdings Corp. | 12 | 100.0% | +66.1% | +63.6% |
| Casdin Eli | GeneDx Holdings Corp. | 12 | 100.0% | +66.1% | +63.6% |
| Casdin Partners GP, LLC | GeneDx Holdings Corp. | 12 | 100.0% | +66.1% | +63.6% |
| Casdin Partners Master Fund, L.P. | GeneDx Holdings Corp. | 12 | 100.0% | +66.1% | +63.6% |
| Vitoc Vlad | MAIA Biotechnology, Inc. | 6 | 100.0% | +56.6% | +0.4% |
| Nair Balan | Liberty Latin America Ltd. | 6 | 100.0% | +41.0% | +2.0% |
| LEVY PAUL S | ContextLogic Holdings Inc. | 6 | 100.0% | +39.0% | +27.6% |
| CERRONE GABRIELE M | OKYO Pharma Ltd | 5 | 100.0% | +37.2% | +11.0% |
| RA CAPITAL MANAGEMENT, L.P. | Artiva Biotherapeutics, Inc. | 37 | 100.0% | +28.8% | +13.0% |
| Kolchinsky Peter | Artiva Biotherapeutics, Inc. | 36 | 100.0% | +28.8% | +13.0% |
| RA Capital Healthcare Fund LP | Artiva Biotherapeutics, Inc. | 36 | 100.0% | +28.8% | +13.0% |
| Shah Rajeev M. | Artiva Biotherapeutics, Inc. | 36 | 100.0% | +28.8% | +13.0% |
| RA Capital Nexus Fund III, L.P. | Artiva Biotherapeutics, Inc. | 19 | 100.0% | +28.8% | +13.0% |
| Theodosopoulos Nikos | Hercules Capital, Inc. | 5 | 100.0% | +27.8% | +27.8% |
| Kliethermes Craig W | RLI CORP | 5 | 100.0% | +26.1% | +0.3% |
| MIGOYA CARLOS A. | Millrose Properties, Inc. | 5 | 100.0% | +24.9% | +1.8% |
| Tompkins Bonnie M | MUNCY COLUMBIA FINANCIAL Corp | 5 | 100.0% | +21.0% | +15.1% |
| COULTER JAMES G | TPG Twin Brook Capital Income Fund | 6 | 100.0% | +19.2% | +19.2% |
| TPG GP A, LLC | TPG Twin Brook Capital Income Fund | 6 | 100.0% | +19.2% | +19.2% |
| WINKELRIED JON | TPG Twin Brook Capital Income Fund | 6 | 100.0% | +19.2% | +19.2% |
| Williams Brenda R H | MUNCY COLUMBIA FINANCIAL Corp | 5 | 100.0% | +15.8% | +12.9% |
| Hilsheimer Lawrence A. | Installed Building Products, Inc. | 11 | 100.0% | +15.6% | +15.6% |
| Quinn William J | INFINITY NATURAL RESOURCES, INC. | 5 | 100.0% | +15.1% | +12.7% |
| Pierce Staci | FIRST US BANCSHARES, INC. | 6 | 100.0% | +10.7% | +5.7% |
| Yemin Ezra Uzi | Delek Logistics Partners, LP | 7 | 100.0% | +8.1% | +3.6% |
跑赢基准比例最低
| 内部人 | 最近买入的公司 | 已到期买入 | 跑赢基准 | 相对基准中位数 | 最差 |
|---|---|---|---|---|---|
| Horne William B. | Hyperscale Data, Inc. | 5 | 0.0% | -76.4% | -81.0% |
| Garg Vishal | Better Home & Finance Holding Co | 7 | 0.0% | -45.7% | -51.5% |
| ROTH JAY W | Venu Holding Corp | 5 | 0.0% | -40.9% | -49.1% |
| BOFA SECURITIES, INC. | Aditxt, Inc. | 12 | 0.0% | -39.1% | -39.1% |
| BANK OF AMERICA CORP /DE/ | PIMCO CALIFORNIA MUNICIPAL INCOME FUND | 70 | 0.0% | -39.1% | -39.1% |
| Talwar Harit | Better Home & Finance Holding Co | 5 | 0.0% | -38.7% | -58.0% |
| STROME MARK E | Zivo Bioscience, Inc. | 6 | 0.0% | -38.2% | -38.2% |
| SWETS LARRY G JR | Greenland Energy Co | 10 | 0.0% | -34.8% | -55.9% |
| Spencer Vance | Better Home & Finance Holding Co | 6 | 0.0% | -31.1% | -45.2% |
| Framework Ventures Management LLC | Better Home & Finance Holding Co | 6 | 0.0% | -31.1% | -45.2% |
| Framework Ventures IV L.P. | Better Home & Finance Holding Co | 6 | 0.0% | -31.1% | -45.2% |
| Framework Ventures IV GP LLC | Better Home & Finance Holding Co | 6 | 0.0% | -31.1% | -45.2% |
| Framework Labs, Inc. | Better Home & Finance Holding Co | 6 | 0.0% | -31.1% | -45.2% |
| Anderson Michael Ernest | Better Home & Finance Holding Co | 6 | 0.0% | -31.1% | -45.2% |
| NELSEN ROBERT | Kardigan, Inc. | 6 | 0.0% | -28.6% | -28.6% |
| GILLIS STEVEN | Kardigan, Inc. | 6 | 0.0% | -28.6% | -28.6% |
| CRANDELL KEITH | Kardigan, Inc. | 6 | 0.0% | -28.6% | -28.6% |
| Burow Kristina | Kardigan, Inc. | 6 | 0.0% | -28.6% | -28.6% |
| Neville Daniel | Advanced Flower Capital Inc. | 6 | 0.0% | -26.6% | -39.6% |
| Lopes Robert A. Jr. | Alight, Inc. / Delaware | 6 | 0.0% | -26.2% | -63.9% |
| Zhida Hong | ADDENTAX GROUP CORP. | 6 | 0.0% | -23.8% | -32.7% |
| Naugle Charles Travis | SILVER BOW MINING CORP. | 5 | 0.0% | -23.0% | -42.9% |
| Baker Brothers Life Sciences LP | Kodiak Sciences Inc. | 7 | 0.0% | -19.8% | -29.9% |
| 667, L.P. | Kodiak Sciences Inc. | 7 | 0.0% | -19.8% | -29.9% |
| Baker Bros. Advisors (GP) LLC | Kodiak Sciences Inc. | 11 | 0.0% | -19.8% | -29.9% |
一笔买入在其后有满 60 个交易日价格时计入。“跑赢基准”是这些买入中收益高于同期基准的比例。某人过去买入的结果不能预测其下一笔。